Business
Earth Science Tech, Inc. (ETST) Considers Dual Listing of its Common Shares on the Canadian Securities Exchange (CSE)
Earth Science Tech, Inc. (ETST) Considers Dual Listing of its Common Shares on the Canadian Securities Exchange (CSE).
About this update from Earth Science Tech, Inc.
[{"type":"text","content":"\nDORAL, Florida, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST\" or the “Company\"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that as the Company is now an “OTC reporting issuer” in the Province of Québec, Canada, its board of directors is considering a dual listing of its common shares on the Canadian Securities Exchange (CSE).\n Earth Science intends to file an application with the CSE in early 2019. Listing could happen as early as in the third quarter of the Company’s current fiscal year and would require certain regulatory approvals that would allow Earth Science to market and sell its common shares to Canadian investors. “The Canadian Securities Exchange has seen significant increases in trading, particularly in the cannabis and CBD space. We feel that by listing on the two exchanges we will attract more investors in both the U.S. and Canada, creating further liquidity and increasing our ability to raise capital in a different market. With our R&D operations conducted in Canada and our CEO residing in Canada, considering a listing on the CSE makes the most sense,” states Earth Science president, director and Chairman Nickolas S. Tabraue. About Earth Science Tech, Inc. (ETST)Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. To learn more, please visit: www.EarthScienceTech.com ETST currently has four wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors: Earth Science Pharmaceutical, Inc. Earth Science Pharmaceutical (\"ESP\") is a wholly-owned subs...